Tangayan, Baby Girl .

HRN: 25-65-89  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/19/2024
AMPICILLIN 250MG (VIAL)
08/19/2024
08/25/2024
IV
160mg
Q12
Neonatal Pneumonia
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: